🇧🇷 Vraylar in Brazil

Vraylar (CARIPRAZINE) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Vraylar in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Brazil

Frequently asked questions

Is Vraylar approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Vraylar in Brazil?

AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.